Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02675439
Title Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aduro Biotech, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.